|
CX-6258 hydrochloride hydrate
|
|
1353858-99-7
|
|
CX-6258 hydrochloride
|
|
1353859-00-3
|
|
Zorifertinib
|
|
1626387-80-1
|
|
Lifirafenib
|
|
1446090-79-4
|
|
CHZ868
|
|
1895895-38-1
|
|
Lavendustin A
|
|
125697-92-9
|
|
PIM-447 dihydrochloride
|
|
1820565-69-2
|
|
JAK3-IN-1
|
|
1805787-93-2
|
|
Ilginatinib maleate
|
|
1354799-87-3
|
|
Ilginatinib
|
|
1239358-86-1
|
|
Ilginatinib hydrochloride
|
|
1239358-85-0
|
|
Naquotinib mesylate
|
|
1448237-05-5
|
|
EGFR-IN-3
|
|
1660963-42-7
|
|
Avitinib maleate
|
|
1557268-88-8
|
|
NRC-2694
|
|
936446-61-6
|
|
PF-06459988
|
|
1428774-45-1
|
|
Neratinib
|
|
698387-09-6
|
|
Tarlox-TKI
|
|
2135696-72-7
|
|
Ruxolitinib (S enantiomer)
|
|
941685-37-6
|
|
Lestaurtinib
|
|
111358-88-4
|
|
Gefitinib hydrochloride
|
|
184475-55-6
|
|
Gefitinib D8
|
|
857091-32-8
|
|
Lapatinib ditosylate
|
|
388082-77-7
|
|
Mutated EGFR-IN-1
|
|
1421372-66-8
|
|
Osimertinib dimesylate
|
|
2070014-82-1
|
|
Niclosamide olamine
|
|
1420-04-8
|
|
Khellin
|
|
82-02-0
|
|
Mutant EGFR inhibitor
|
|
1421373-62-7
|
|
CP-724714
|
|
383432-38-0
|
|
NVP-BSK805 dihydrochloride
|
|
1942919-79-0
|
|
Homoharringtonine
|
|
26833-87-4
|
|
NSC 74859
|
|
501919-59-1
|
|
Icotinib Hydrochloride
|
|
1204313-51-8
|
|
Baricitinib phosphate
|
|
1187595-84-1
|
|
RGB-286638
|
|
784210-87-3
|
|
AZD1208
|
|
1204144-28-4
|
|
Tyrphostin 23
|
|
118409-57-7
|
|
Rociletinib hydrobromide
|
|
1446700-26-0
|
|
Osimertinib mesylate
|
|
1421373-66-1
|
|
AG-825
|
|
149092-50-2
|
|
Cerdulatinib hydrochloride
|
|
1369761-01-2
|
|
SH-4-54
|
|
1456632-40-8
|
|
GDC-0339
|
|
1428569-85-0
|
|
Itacitinib adipate
|
|
1334302-63-4
|
|
Tarloxotinib bromide
|
|
1636180-98-7
|
|
Ochromycinone
|
|
111540-00-2
|
|
TCS PIM-1 1
|
|
491871-58-0
|
|
CX-6258
|
|
1202916-90-2
|
|
Napabucasin
|
|
83280-65-3
|
|
GLPG0634 analog
|
|
1206101-20-3
|
|
Alantolactone
|
|
546-43-0
|
|
Cryptotanshinone
|
|
35825-57-1
|
|
Diosgenin
|
|
512-04-9
|
|
Artesunate
|
|
88495-63-0
|
|
Cyasterone
|
|
17086-76-9
|
|
Nitidine chloride
|
|
13063-04-2
|
|
Curculigoside
|
|
85643-19-2
|
|
Scutellarin
|
|
27740-01-8
|
|
Corylifol A
|
|
775351-88-7
|
|
Tephrosin
|
|
76-80-2
|
|
Brevilin A
|
|
16503-32-5
|
|
β-Hydroxyisovalerylshikonin
|
|
7415-78-3
|
|
Astragaloside VI
|
|
84687-45-6
|
|
Reticuline
|
|
485-19-8
|
|
Triacetylresveratrol
|
|
42206-94-0
|
|
Hispidulin
|
|
1447-88-7
|
|
Mogrol
|
|
88930-15-8
|
|
Sulforaphene
|
|
592-95-0
|
|
Ginsenoside Rk1
|
|
494753-69-4
|
|
Arnicolide D
|
|
34532-68-8
|
|
Garcinone C
|
|
76996-27-5
|
|
Coumermycin A1
|
|
4434-05-3
|
|
EGFR Protein Tyrosine Kinase Substrate
|
|
945830-38-6
|
|
Cetuximab
|
|
205923-56-4
|
|
Trastuzumab
|
|
180288-69-1
|
|
Pertuzumab
|
|
380610-27-5
|
|
ZD-4190
|
|
413599-62-9
|
|
GNE-495
|
|
1449277-10-4
|
|
TBHQ
|
|
1948-33-0
|
|
M2698
|
|
1379545-95-5
|
|
RAF709
|
|
1628838-42-5
|
|
(Rac)-JBJ-04-125-02
|
|
2140807-05-0
|
|
Mobocertinib
|
|
1847461-43-1
|
|
Mobocertinib succinate
|
|
2389149-74-8
|
|
CK2/ERK8-IN-1
|
|
1085822-09-8
|
|
Chrysophanol
|
|
481-74-3
|
|
JCN037
|
|
2305154-31-6
|
|
JAK2-IN-6
|
|
353512-04-6
|
|
(E)-Necrosulfonamide
|
|
1360614-48-7
|
|
APS-2-79
|
|
2002381-25-9
|
|
NCB-0846
|
|
1792999-26-8
|
|
GS-444217
|
|
1262041-49-5
|
|
LY3214996
|
|
1951483-29-6
|
|
TC13172
|
|
2093393-05-4
|
|
AX-15836
|
|
2035509-96-5
|
|
AD80
|
|
1384071-99-1
|
|
Sorafenib Tosylate
|
|
475207-59-1
|
|
BRAF inhibitor
|
|
918505-61-0
|
|
SB 203580 hydrochloride
|
|
869185-85-3
|
|
Sorafenib
|
索拉非尼
|
284461-73-0
|